| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-03 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $1.83B | $1.93B | $2.06B |
| YoY Revenue Growth % | -5.4% | -6.3% | — |
| Gross Profit | $398.8M | $421.9M | — |
| Gross Margin % | 21.8% | 21.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $97.1M | -$177.3M | $80.4M |
| Operating Margin % | 5.3% | -9.2% | 3.9% |
| Net Income (GAAP) | -$43.3M | -$251.3M | -$66.2M |
| EBITDA (Normalized) | $121.7M | -$155.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $101.4M | $130.9M | $247.8M |
| Capital Expenditures (CapEx) | $30.6M | $27.3M | — |
| Free Cash Flow (FCF) | $70.7M | $103.7M | $247.8M |
| FCF Margin % | 3.9% | 5.4% | 12.0% |
| Return on Invested Capital (ROIC %) | 3.3% | -5.6% | — |
| Cash & Short-Term Equivalents | $56.3M | $50.6M | — |
| Total Debt (Short + Long Term) | $1.95B | $2.01B | — |
| Total Stockholders' Equity | $452.9M | $524.8M | — |